ATAI

ATAI Life Sciences N.V. (ATAI)

About ATAI Life Sciences N.V. (ATAI)

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Details

Daily high

$1.26

Daily low

$1.15

Price at open

$1.19

52 Week High

$2.85

52 Week Low

$1.03

Market cap

199.7M

Dividend yield

0.00%

Volume

2.5M

Avg. volume

1.3M

P/E ratio

-1.48

ATAI Life Sciences N.V. News